Palantir (PLTR): Risk vs. Reality

At Equity Risk Sciences, we don’t deal in speculation—we quantify risk. Palantir (PLTR) may be growing, but is it a safe investment? The data tells a different story.

• Extreme Valuation Risks: Investors once paid $267B for a company with just $3B in revenue and $500M in earnings—a 100x Price-to-Sales ratio.
• Fiduciary Risk Rating (FRR): 94 (on a 0 (best) to 100 (worst) scale) Our independent data shows that historically, stocks at these levels fail.

Even if earnings grow tenfold, the current market cap is disconnected from reality. Prudent investors know: market history matters.

Are you making data-driven decisions, or chasing imagination-driven valuations?

#EquityRiskSciences #Palantir #PLTR #StockAnalysis #RiskManagement #InvestmentRisk #FiduciaryDuty #DataDrivenInvesting #MarketBubbles

By Raymond M. Mullaney, CEO
March 12, 2025